Shionogi & Co logo

4507 - Shionogi & Co News Story

¥6234 32.0  0.5%

Last Trade - 14/08/20

Sector
Healthcare
Size
Large Cap
Market Cap £13.56bn
Enterprise Value £11.07bn
Revenue £2.23bn
Position in Universe 68th / 3863

BRIEF-Shionogi & Co Ltd - Will Develop A Prophylactic Vaccine For Covid-19

Mon 27th April, 2020 7:06am
April 27 (Reuters) - Shionogi & Co Ltd  4507.T :
    * WILL DEVELOP A PROPHYLACTIC VACCINE FOR COVID-19
    * DECIDED TO POSITION THE DEVELOPMENT OF COVID-19 VACCINE AS
A
TOP-PRIORITY PROJECT, ALONGSIDE DISCOVERY OF COVID-19
THERAPEUTIC DRUGS
    * COORDINATING PLANS WITH RELEVANT PARTIES INCLUDING JAPAN'S
HEALTH MINISTRY, PHARMACEUTICALS AND MEDICAL DEVICES AGENCY, AND
THE NATIONAL INSTITUTE OF INFECTIOUS DISEASES (NIID), IN ORDER
TO START CLINICAL TRIALS WITHIN THE YEAR

Source text for Eikon:  ID:nTSPa61b1c 
Further company coverage:  4507.T
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.